An organ-on-chip model of pulmonary arterial hypertension identifies a BMPR2-SOX17-prostacyclin signalling axis.
Alexander J Ainscough,
Timothy J Smith,
Maike Haensel,
Christopher J Rhodes,
Adam Fellows,
Harry J Whitwell,
Eleni Vasilaki,
Kelly Gray,
Adrian Freeman,
Luke S Howard,
John Wharton,
Benjamin Dunmore,
Paul D Upton,
Martin R Wilkins,
Joshua B Edel,
Beata Wojciak-Stothard
Dec 09, 2022
Pulmonary arterial hypertension (PAH) is an unmet clinical need. The lack of models of human disease is a key obstacle to drug development. We present a biomimetic model of pulmonary arterial endothelial-smooth muscle cell...